Suppr超能文献

Pan-Gα 偶联毒蕈碱型乙酰胆碱受体正变构调节剂的构效关系。

Structure-Activity Relationships of Pan-Gα Coupled Muscarinic Acetylcholine Receptor Positive Allosteric Modulators.

机构信息

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences , Monash University , Parkville , Victoria 3052 , Australia.

Departments of Pharmacology & Chemistry, Vanderbilt Center for Neuroscience Drug Discovery , Vanderbilt University , Nashville , Tennessee 37232 , United States.

出版信息

ACS Chem Neurosci. 2018 Jul 18;9(7):1818-1828. doi: 10.1021/acschemneuro.8b00136. Epub 2018 Apr 30.

Abstract

Recent years have seen a large increase in the discovery of allosteric ligands targeting muscarinic acetylcholine receptors (mAChRs). One of the challenges in screening such compounds is to understand their mechanisms of action and define appropriate parameter estimates for affinity, cooperativity and efficacy. Herein we describe the mechanisms of action and structure-activity relationships for a series of "pan-G-coupled" muscarinic acetylcholine (ACh) receptor (mAChR) positive allosteric modulators (PAMs). Using a combination of radioligand binding, functional inositol phosphate accumulation assays, receptor alkylation and operational data analysis, we show that most compounds in the series derive their variable potency and selectivity from differential cooperativity at the M, M and M mAChRs. None of the PAMs showed greater than 10-fold subtype selectivity for the agonist-free receptor, but VU6007705, VU6007678, and VU6008555 displayed markedly increased cooperativity compared to the parent molecule and M mAChR-preferring PAM, ML380 (αβ > 100), in the presence of ACh. Most of the activity of these PAMs derives from their ability to potentiate ACh binding affinity at mAChRs, though VU6007678 was notable for also potentiating ACh signaling efficacy and robust allosteric agonist activity. These data provide key insights for the future design of more potent and subtype-selective mAChR PAMs.

摘要

近年来,针对毒蕈碱型乙酰胆碱受体 (mAChR) 的变构配体的发现大量增加。筛选此类化合物的挑战之一是了解其作用机制并确定亲和力、协同性和效力的适当参数估计。在此,我们描述了一系列“pan-G-coupled”毒蕈碱乙酰胆碱 (ACh) 受体 (mAChR) 正变构调节剂 (PAM) 的作用机制和结构-活性关系。我们使用放射性配体结合、功能性肌醇磷酸盐积累测定、受体烷基化和操作数据分析的组合,表明该系列中的大多数化合物的可变效力和选择性来自于在 M、M 和 M mAChRs 上的不同协同作用。该系列中的没有一种 PAM 对无激动剂受体显示出大于 10 倍的亚型选择性,但与母体分子和 M mAChR 偏好的 PAM ML380(αβ > 100)相比,VU6007705、VU6007678 和 VU6008555 在 ACh 存在下显示出明显增加的协同作用。这些 PAM 的大部分活性来自于它们增强 mAChR 上 ACh 结合亲和力的能力,尽管 VU6007678 还增强了 ACh 信号传导效力和强大的变构激动剂活性。这些数据为更有效和亚型选择性 mAChR PAM 的未来设计提供了关键见解。

相似文献

1
Structure-Activity Relationships of Pan-Gα Coupled Muscarinic Acetylcholine Receptor Positive Allosteric Modulators.
ACS Chem Neurosci. 2018 Jul 18;9(7):1818-1828. doi: 10.1021/acschemneuro.8b00136. Epub 2018 Apr 30.
2
Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
Mol Pharmacol. 2016 Oct;90(4):427-36. doi: 10.1124/mol.116.104182. Epub 2016 Jul 26.
4
Discovery and structure-activity relationships study of positive allosteric modulators of the M muscarinic acetylcholine receptor.
Bioorg Med Chem. 2020 Jul 1;28(13):115531. doi: 10.1016/j.bmc.2020.115531. Epub 2020 Apr 30.
5
Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5675-84. doi: 10.1073/pnas.1612353113. Epub 2016 Sep 6.
6
Probing the binding site of novel selective positive allosteric modulators at the M muscarinic acetylcholine receptor.
Biochem Pharmacol. 2018 Aug;154:243-254. doi: 10.1016/j.bcp.2018.05.009. Epub 2018 May 17.
7
Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.
J Biol Chem. 2014 Nov 28;289(48):33701-11. doi: 10.1074/jbc.M114.604967. Epub 2014 Oct 17.
9
Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284.
Mol Pharmacol. 2016 Sep;90(3):177-87. doi: 10.1124/mol.116.104737. Epub 2016 Jul 5.

引用本文的文献

1
Cryo-EM reveals an extrahelical allosteric binding site at the M mAChR.
Nat Commun. 2025 Jul 31;16(1):7046. doi: 10.1038/s41467-025-62212-z.
2
Cryo-EM reveals a new allosteric binding site at the M mAChR.
bioRxiv. 2025 Feb 8:2025.02.05.636602. doi: 10.1101/2025.02.05.636602.
4
Surface Plasmon Resonance Screening to Identify Active and Selective Adenosine Receptor Binding Fragments.
ACS Med Chem Lett. 2022 Jun 6;13(7):1172-1181. doi: 10.1021/acsmedchemlett.2c00099. eCollection 2022 Jul 14.
5
Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.
Front Aging Neurosci. 2022 May 18;14:869507. doi: 10.3389/fnagi.2022.869507. eCollection 2022.
6
to Translation of Allosteric Modulator Concentration-Effect Relationships: Implications for Drug Discovery.
ACS Pharmacol Transl Sci. 2019 Nov 15;2(6):442-452. doi: 10.1021/acsptsci.9b00062. eCollection 2019 Dec 13.
7
Analytical Pharmacology: How Numbers Can Guide Drug Discovery.
ACS Pharmacol Transl Sci. 2019 Jan 3;2(1):9-17. doi: 10.1021/acsptsci.8b00057. eCollection 2019 Feb 8.

本文引用的文献

1
"Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu Allosteric Ligands.
Mol Pharmacol. 2018 May;93(5):504-514. doi: 10.1124/mol.117.111518. Epub 2018 Mar 7.
2
Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
Mol Pharmacol. 2016 Oct;90(4):427-36. doi: 10.1124/mol.116.104182. Epub 2016 Jul 26.
3
Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.
J Biol Chem. 2014 Nov 28;289(48):33701-11. doi: 10.1074/jbc.M114.604967. Epub 2014 Oct 17.
5
Advances in G protein-coupled receptor allostery: from function to structure.
Mol Pharmacol. 2014 Nov;86(5):463-78. doi: 10.1124/mol.114.094342. Epub 2014 Jul 24.
7
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.
J Biol Chem. 2014 Feb 28;289(9):6067-79. doi: 10.1074/jbc.M113.539080. Epub 2014 Jan 17.
8
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.
Nature. 2013 Nov 14;503(7475):295-9. doi: 10.1038/nature12595. Epub 2013 Oct 13.
10
Spirocyclic replacements for the isatin in the highly selective, muscarinic M1 PAM ML137: the continued optimization of an MLPCN probe molecule.
Bioorg Med Chem Lett. 2013 Mar 15;23(6):1860-4. doi: 10.1016/j.bmcl.2013.01.017. Epub 2013 Jan 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验